Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Inflammation  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR. "Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort." Vasc Med. 2007;12(4):267-73.
Klein R, Sharrett AR, Klein BE, et al. "Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study." Arterioscler Thromb Vasc Biol. 2000;20(6):1644-50.
Tang W, Yao L, Hoogeveen RC, et al. "The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Study." Angiology. 2019;70(2):130-140.
Liao D, Heiss G, Chinchilli VM, et al. "Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study." J Expo Anal Environ Epidemiol. 2005;15(4):319-28.
Prizment AE, Anderson KE, Visvanathan K, Folsom AR. "Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study." Cancer Epidemiol Biomarkers Prev. 2011;20(2):297-307.
Garg PK, Bartz TM, Norby FL, et al. "Association of lipoprotein-associated phospholipase A and risk of incident atrial fibrillation: Findings from 3 cohorts." Am Heart J. 2018;197:62-69.
Walker KA, B Windham G, Brown CH, et al. "The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study." J Alzheimers Dis. 2018;66(3):1041-1052.
Nettleton JA, Matijevic N, Follis JL, Folsom AR, Boerwinkle E. "Associations between dietary patterns and flow cytometry-measured biomarkers of inflammation and cellular activation in the Atherosclerosis Risk in Communities (ARIC) Carotid Artery MRI Study." Atherosclerosis. 2010;212(1):260-7.
B
Folsom AR, Desvarieux M, Nieto JF, Boland LL, Ballantyne CM, Chambless LE. "B vitamin status and inflammatory markers." Atherosclerosis. 2003;169(1):169-74.
Hunt KJ, Pankow JS, Offenbacher S, et al. "B-mode ultrasound-detected carotid artery lesions with and without acoustic shadowing and their association with markers of inflammation and endothelial activation: the atherosclerosis risk in communities study." Atherosclerosis. 2002;162(1):145-55.
Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond WD. "Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology." Thromb Res. 2016;144:127-32.
D
Beck JD, Pankow J, Tyroler HA, Offenbacher S. "Dental infections and atherosclerosis." Am Heart J. 1999;138(5 Pt 2):S528-33.
Luft VC, Schmidt M I, Pankow JS, et al. "Dipeptidyl peptidase IV and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study." Diabetes Care. 2010;33(5):1109-11.
Ligthart S, Marzi C, Aslibekyan S, et al. "DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases." Genome Biol. 2016;17(1):255.
E
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. "Early-life and adult socioeconomic status and inflammatory risk markers in adulthood." Eur J Epidemiol. 2007;22(1):55-66.
F
Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G. "Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities." Obes Res. 2000;8(4):279-86.
H
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
I
Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. "Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2009;53(4):596-605.
Duncan BB, Schmidt M I, Chambless LE, Folsom AR, Heiss G. "Inflammation markers predict increased weight gain in smoking quitters." Obes Res. 2003;11(11):1339-44.
M
Schmidt MI, Duncan BB, Sharrett AR, et al. "Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study." Lancet. 1999;353(9165):1649-52.
Walker KA, Walston J, Gottesman RF, Kucharska-Newton AMaria, Palta P. "Midlife Systemic Inflammation Is Associated With Frailty in Later Life: The ARIC Study." J Gerontol A Biol Sci Med Sci. 2019;74(3):343-349.
Walker KA, Hoogeveen RC, Folsom AR, et al. "Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study." Neurology. 2017;89(22):2262-2270.
Kocarnik JM, Pendergrass SA, Carty CL, et al. "Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(2):178-88.
N
Folsom AR. ""New" risk factors for atherosclerotic diseases." Exp Gerontol. 1999;34(4):483-90.
P
Kraja AT, Chasman DI, North KE, et al. "Pleiotropic genes for metabolic syndrome and inflammation." Mol Genet Metab. 2014;112(4):317-38.
R
Wong T Y, Klein R, A Sharrett R, et al. "Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons." JAMA. 2002;287(19):2528-33.
S
Walker KA, Gottesman RF, Wu A, et al. "Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study." Neurology. 2019;92(11):e1256-e1267.